UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

Journal of clinical oncology, 2018-06, Vol.36 (17), p.1702-1709

2018

Volltextzugriff (PDF)

Combinatorial treatment with CTO and temozolomide in sc-implanted human LOX 1MVI melanoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e19006-e19006

2012

Volltextzugriff (PDF)

Combinatorial treatment using CTO with paclitaxel or paclitaxel orotate in sc-implanted human OVCAR-5 ovarian tumor model

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15515-e15515

2012

Volltextzugriff (PDF)

Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2064-2064

2016

Volltextzugriff (PDF)

Phase IB trial of carboxyamidotriazole orotate (CTO) and temozolomide for recurrent malignant glioma (MG): A novel mechanism for modulation of multiple oncogenic pathways

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2071-2071

2014

Volltextzugriff (PDF)

Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e13004-e13004

2015

Volltextzugriff (PDF)

Carboxyamidotriazole orotate (CTO) in combination with bevacizumab (BEV) for adult patients with recurrent malignant glioma post-BEV failure: Phase 1

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2067-2067

2015

Volltextzugriff (PDF)

Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2060-2060

2016

Volltextzugriff (PDF)

AT-48A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v19-v19

2014

Volltextzugriff (PDF)

Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2062-2062

2015

Volltextzugriff (PDF)

A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2518-2518

2013

Volltextzugriff (PDF)

NI-57DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v150-v151

2014

Volltextzugriff (PDF)

NI-57 DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v150-v151

2014

Volltextzugriff (PDF)

AT-48 A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v19-v19

2014

Volltextzugriff (PDF)

Influence of Exogenous Cyclic 3′: 5′-AMP on Growth, Prostaglandin Biosynthesis, and Prolactin Binding Capacity of Cultured Mammary Tumor Cells

Annals of the New York Academy of Sciences, 1986-05, Vol.463 (1), p.171-173

1986

Volltextzugriff (PDF)

Effect of Omega-3 Fatty Acids on Growth of a Rat Mammary Tumor

JNCI : Journal of the National Cancer Institute, 1984-08, Vol.73 (2), p.457-461

1984

Volltextzugriff (PDF)

Dietary Fat and Mammary Cancer. II. Modulation of Serum and Tumor Lipid Composition and Tumor Prostaglandins by Different Dietary Fats: Association With Tumor Incidence Patterns

JNCI : Journal of the National Cancer Institute, 1986-07, Vol.77 (1), p.43-51

1986

Volltextzugriff (PDF)

Prostaglandins and cancer

CA: a cancer journal for clinicians, 1983-11, Vol.33 (6), p.322-332

Karmali, Rashida A.

1983

Volltextzugriff (PDF)

BURKITT'S TUMOUR, LYMPHOCYTES, AND PROLACTIN

The Lancet (British edition), 1977-09, Vol.310 (8039), p.654-654

1977

Volltextzugriff (PDF)

PROLACTIN AND THE IMMUNE RESPONSE

The Lancet (British edition), 1974-07, Vol.304 (7872), p.106-107

1974

Volltextzugriff (PDF)

ROLE OF PINEAL GLAND IN ÆTIOLOGY AND TREATMENT OF BREAST CANCER

The Lancet (British edition), 1978-11, Vol.312 (8097), p.1001-1002

1978

Volltextzugriff (PDF)

Aspirin, indomethacin, catecholamine and prostaglandin interactions on rat arterioles and rabbit hearts

Nature (London), 1974-08, Vol.250 (5465), p.425-426

1974

Volltextzugriff (PDF)

PROLACTIN AND PROSTAGLANDIN SYNTHESIS

The Lancet (British edition), 1974-11, Vol.304 (7889), p.1154-1154

1974

Volltextzugriff (PDF)

Letter: Prolactin, bromocriptine, and haemostasis

BMJ, 1975-08, Vol.3 (5978), p.307-307

1975

Volltextzugriff (PDF)

Suppression of monosodium urate crystal—induced acute inflammation by diets enriched with gamma‐linolenic acid and eicosapentaenoic acid

Arthritis and rheumatism, 1988-12, Vol.31 (12), p.1543-1551

1988

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

Combinatorial treatment with CTO and temozolomide in sc-implanted human LOX 1MVI melanoma

Combinatorial treatment using CTO with paclitaxel or paclitaxel orotate in sc-implanted human OVCAR-5 ovarian tumor model

Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG)

Phase IB trial of carboxyamidotriazole orotate (CTO) and temozolomide for recurrent malignant glioma (MG): A novel mechanism for modulation of multiple oncogenic pathways

Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG)

Carboxyamidotriazole orotate (CTO) in combination with bevacizumab (BEV) for adult patients with recurrent malignant glioma post-BEV failure: Phase 1

Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)

AT-48A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE

Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)

A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors

NI-57DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

NI-57 DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

AT-48 A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE

Influence of Exogenous Cyclic 3′: 5′-AMP on Growth, Prostaglandin Biosynthesis, and Prolactin Binding Capacity of Cultured Mammary Tumor Cells

Effect of Omega-3 Fatty Acids on Growth of a Rat Mammary Tumor

Dietary Fat and Mammary Cancer. II. Modulation of Serum and Tumor Lipid Composition and Tumor Prostaglandins by Different Dietary Fats: Association With Tumor Incidence Patterns

Prostaglandins and cancer

BURKITT'S TUMOUR, LYMPHOCYTES, AND PROLACTIN

PROLACTIN AND THE IMMUNE RESPONSE

ROLE OF PINEAL GLAND IN ÆTIOLOGY AND TREATMENT OF BREAST CANCER

Aspirin, indomethacin, catecholamine and prostaglandin interactions on rat arterioles and rabbit hearts

PROLACTIN AND PROSTAGLANDIN SYNTHESIS

Letter: Prolactin, bromocriptine, and haemostasis

Suppression of monosodium urate crystal—induced acute inflammation by diets enriched with gamma‐linolenic acid and eicosapentaenoic acid

Aktive Filter

Suchergebnisse filtern